(Q54479575)

30 May 2018

title

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer. (English)

1 reference

30 May 2018

author name string

Jennifer I Hare

series ordinal

1

1 reference

30 May 2018

Elaine H Moase

series ordinal

2

1 reference

30 May 2018

Theresa M Allen

series ordinal

3

1 reference

30 May 2018

publication date

8 October 2012

1 reference

30 May 2018

Journal of Drug Targeting

published in

1 reference

30 May 2018

volume

21

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

87-96

1 reference

30 May 2018

cites work

Adventures in targeting

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

The development of combretastatin A4 phosphate as a vascular targeting agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Endothelial cell proliferation as a novel approach to targeting tumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Isolation of a tumor factor responsible for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Normalization of the vasculature for treatment of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Development of ligand-targeted liposomes for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

RGD and other recognition sequences for integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Liposomal targeting of angiogenic vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Anti-VEGF/VEGFR therapy for cancer: reassessing the target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Vascular targeting agents as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

First-line Herceptin monotherapy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2012.729215

10.3109/1061186X.2012.729215

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

release_3hn3jjapdfcpzixlx2xfzqqnyi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3hn3jjapdfcpzixlx2xfzqqnyi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

30 May 2018